Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.77 USD | +4.48% | -2.44% | -3.22% |
Financials (USD)
Sales 2024 * | 64.83M | Sales 2025 * | 120M | Capitalization | 2.96B |
---|---|---|---|---|---|
Net income 2024 * | -411M | Net income 2025 * | -442M | EV / Sales 2024 * | 22.6 x |
Net cash position 2024 * | 1.49B | Net cash position 2025 * | 1.27B | EV / Sales 2025 * | 14.1 x |
P/E ratio 2024 * |
-7.85
x | P/E ratio 2025 * |
-7.71
x | Employees | 445 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.11% |
Latest transcript on Denali Therapeutics Inc.
1 day | +4.48% | ||
1 week | -2.44% | ||
Current month | +5.01% | ||
1 month | -11.05% | ||
3 months | -6.48% | ||
6 months | -3.53% | ||
Current year | -3.22% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Schuth
FOU | Founder | 50 | 13-10-13 |
Ryan Watts
FOU | Founder | 48 | 13-10-13 |
Joe Lewcock
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vicki Sato
CHM | Chairman | 75 | 15-03-31 |
Jay Flatley
BRD | Director/Board Member | 71 | 15-03-31 |
David Schenkein
BRD | Director/Board Member | 66 | 15-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.31% | 0 M€ | 0.00% | - | |
0.31% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 20.77 | +4.48% | 801,711 |
24-03-26 | 19.88 | +0.05% | 1,246,396 |
24-03-25 | 19.87 | +1.27% | 932,394 |
24-03-22 | 19.62 | -6.57% | 992,823 |
24-03-21 | 21 | -1.36% | 1,173,255 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.22% | 2.96B | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.69% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |